Inspection Record

Avella of Deer Valley, Inc. Store 38 — FDA 483 Findings

US FDAInspected 2018-04-20Published 2026-03-23 3 findingsQuality unit oversightStability and storageLabeling and packaging

Inspectors Nayan J Patel · Rumany C PennThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

2Stability and storage

Drug products are not stored under appropriate conditions of temperature and humidity so that thei identity, strength, quaJity, and purity are not affected.

3Labeling and packaging

The labels of your outsourcing facility's drug products are deficient.

About this record

Extracted automatically from the document US FDA published on 2026-03-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Avella of Deer Valley, Inc. Store 38 company profile — full history US FDA documents, 2026 Go to Findings search